PROMISE Project

Paving the way to RSV prevention, treatment and immunisation. IMI funded project GA 101034339.

[PROMISE Project @PROMISE_IMI]

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking JU and others. Any related tweets reflect only the views of the author.

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉D2.12 Final Progress Report Task 2.2

🔗https://t.co/99N6ILngon

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉D2.4 Report on identification of adverse events for safety evaluations of RSV vaccination and monoclonal antibodies

🔗https://t.co/pABJo0h3XC

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉D2.8 Identification of methodological challenges

🔗https://t.co/k66e8dojkg

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉D1.5 Report on global impact of COVID-19 on RSV burden

🔗 https://t.co/a6LhNtLqgU

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉 D1.3 Report on RSV burden in pregnant women

🔗 https://t.co/6YDXVgyUZo

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉 D1.2 Report on variation in global RSV seasonality by subtypes

🔗 https://t.co/s7KHzFekkp

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

📢 New deliverable out!

👉 D1.1 Report on novel clinical scores for RSV severity

🔗 https://t.co/wzQ1EM4zoS

#PROMISE #RSV #RSVPatientNetwork

@CCVernhes @IHIEurope @ReSViNET @PagetPhd

[PROMISE Project @PROMISE_IMI]

@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #16⤵

“France, Portugal and Slovenia reported sporadic RSV activity. Austria, Belgium and the Netherlands reported baseline RSV activity.”

Full bulletin here 🔗https://t.co/7WQLPPo4aw

[PROMISE Project @PROMISE_IMI]

@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #14⤵

“In reporting week 14 Austria, France and Portugal and Slovenia reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”

Full bulletin here 👉https://t.co/7WQLPPo4aw

[PROMISE Project @PROMISE_IMI]

@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #12⤵

“In week 12, Slovenia reported RSV activity. Austria, France and Portugal reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”

👉https://t.co/7WQLPPo4aw

[PROMISE Project @PROMISE_IMI]

Our focus always remained clear: to develop innovative immunisation tools and therapeutics to combat this potentially deadly virus, especially in our paediatric and elderly populations👶👵

Thank you everyone for your support & participation to date!

@IHIEurope

[Charlotte Vernhes @CCVernhes]

Celebrating the achievements of the @PROMISE_IMI, including the European #RSV surveillance bulletin published biweekly since October 2023, which has benefited from continuous improvement since its launch thanks to collaborative work with partners.

[PROMISE Project @PROMISE_IMI]

Dr.Edoardo Colzani highlights the urgent need for more Respiratory Syncytial Virus research and better surveillance for older adults.

With #RSV set to become notifiable disease in the EU, it's time for action. 🛡️

Watch the full webinar here:https://t.co/HxUreoxwuM

@ihieurope

[PROMISE Project @PROMISE_IMI]

The path to combatting Respiratory Syncytial Virus (#RSV) lies in highlighting the importance of vaccination to our policymakers.

Investing in RSV vaccines is not just a measure of immediate protection but a long-term strategy to safeguard us all. 🏘️
ℹ️: https://t.co/HxUreoxwuM

[PROMISE Project @PROMISE_IMI]

At the PROMISE webinar, the call for action was clear: adopting #RSV prevention strategies is a moral duty. Our healthcare must protect the most vulnerable - infants and the elderly. 🛡️

💬 Explore the full debate: https://t.co/HxUreoxwuM

@ihieurope @sanofi @TeamItResearch

[PROMISE Project @PROMISE_IMI]

@HamentMarie stresses #RSV immunisation's critical role in public health, urging action to protect the vulnerable.

🛡️ Join us in fighting this preventable risk.

Uncover the full debate: https://t.co/HxUreoxwuM

@ihieurope @sanofi @TeamItResearch

[PROMISE Project @PROMISE_IMI]

#RSV is now preventable. Member States must act to get prevention tools where they're needed most.

Let's tackle this together. 🩺🇪🇺

Watch the full webinar: https://t.co/OQQuaQvm8r

@ihieurope @sanofi @TeamItResearch @fedemartinon

[PROMISE Project @PROMISE_IMI]

European #RSV Surveillance Bulletin #10⤵

“Austria, Denmark, France and the Netherlands reported that the trend in percentage of RSV positive cases is decreasing. The trend in percentage of RSV positive cases remains stable in Slovenia.”

👉https://t.co/7WQLPPo4aw

[PROMISE Project @PROMISE_IMI]

Dr. Edoardo Colzani calls for more research and better surveillance to combat RSV, especially in older adults.

With RSV on track to become a notifiable disease in the EU, we're at a critical juncture. 🏥

Discover the full debate, here: https://t.co/HxUreoxwuM

@IHIEurope

[PROMISE Project @PROMISE_IMI]

@MOdemyr highlighted the widespread nature of Respiratory Syncytial Virus (#RSV) and its severe impact on our most vulnerable populations.

Let's boost EU Member State’s efforts in surveillance, awareness and prevention to protect those at risk. 🔐

ℹ️:https://t.co/HxUreoxwuM

[PROMISE Project @PROMISE_IMI]

By incorporating #RSV consequences into economic assessments, we can improve decision-making and enhance national responses. 💶

Delve into this and other insights from Prof. Dr. med. Monika Gappa, from the @EuroRespSoc: https://t.co/SLLUcqZlIF